DENOISING OF DYNAMIC RESONANCE SPECTROSCOPIC IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN Read more about DENOISING OF DYNAMIC RESONANCE SPECTROSCOPIC IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN US Application 17/576,283Filed on 2022-01-14
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 US Application 17/608,832Filed on 2021-11-04
Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development Read more about Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development Canada3139507Filed on 2020-05-06
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION Hong Kong62022047561.5Filed on 2022-02-04
T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY Read more about T CELLS HAVING ENHANCED ANTI-TUMOR ACTIVITY US Application 17/633,414Filed on 2022-02-07
Chimeric Antigen Receptors Targeting CD-19 Read more about Chimeric Antigen Receptors Targeting CD-19 Japan2021-215427Filed on 2021-12-29
CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING CD-19 US Application 17/557,845Filed on 2021-12-21
ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS Read more about ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS Japan2021-203953Filed on 2021-12-16
Methods of Analyzing Virus-Derived Therapeutics Read more about Methods of Analyzing Virus-Derived Therapeutics MacaoJ/005746Filed on 2022-01-19
CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON Read more about CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS AND A COSTIMULATORY SIGNAL PROTEIN USING A VLP-REPLICON The Netherlands20150087.3Filed on 2014-12-16